Navigation auf uzh.ch

Journal Database (Zurich Open Repository and Archive)

Journal: The Lancet Haematology ISSN (E) 2352-3026 ISSN (L) 2352-3026
Publisher: (2674) Elsevier (Alias: Elsevier, Elsevier BV, Elsevier Ltd, Elsevier Inc., Elsevier Masson, Elsevier Australia, Elsevier Ltd., Elsevier BV * North-Holland, Elsevier Doyma, Elsevier Editora Ltda, Elsevier Espana, Elsevier France * Editions Scientifiques et Medicales, Elsevier GmbH, Elsevier GmbH - Urban und Fischer, Elsevier Health Sciences, Elsevier Ireland Ltd., Elsevier Japan KK, Elsevier Oncology, Elsevier Science Publishers Ltd., Elsevier S.A., Pergamon Press)

There are no additional documents for this Publisher/Journal.
Item Type: Journal/Series
Publication Type: Journal
Refereed: Yes
OA Permissions:
Article VersionAllowedEmbargoS/R Policy IdConditionsLicenseCopyright Owner
Accepted ManuscriptYes6 Months1274Publisher copyright and source must be acknowledged
Must link to publisher version
CC BY-NC-ND
Published PDFNo1274
Published PDFNo3323
Published PDFHybrid3323Published source must be acknowledged with citationCC BY
Published PDFHybrid3323Published source must be acknowledged with citationCC BY
Published PDFHybrid3323Published source must be acknowledged with citationCC BY-NC-ND 4.0, CC BY-NC
DOAJ: No, journal is not listed in DOAJ
Additional Information: Valid for articles published after May 1st, 2015: Author's post-print (accepted manuscript) on open access repository after an embargo period of between 12 months and 48 months see Journal Embargo Period List (pdf) (see link above "Publisher's Policy". This information is not valid for Open Access journals (see specific policy on website). Accepted manuscripts should be published under the CC-BY-NC-ND 4.0 license.
URL:
URLURL Type
http://download.thelancet.com/flatcontentassets/authors/lancet-information-for-authors.pdfGuidelines for Authors
http://www.thelancet.com/lancet/information-for-authors/disclosure-of-resultsDisclosure of results before publication
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2960720-5/fulltextThe Lancet journals welcome a new open access policy
http://www.thelancet.com/lancet-information-for-authors/after-publicationWhat happens after publication?
https://www.elsevier.com/__data/assets/pdf_file/0005/78476/external-embargo-list.pdfJournal Embargo Period List
https://www.elsevier.com/__data/assets/pdf_file/0011/78473/UK-Embargo-Periods.pdfJournal Embargo List for UK Authors
https://www.elsevier.com/about/open-science/open-accessOpen access
https://www.elsevier.com/about/policies/open-access-licensesOpen access licenses
https://www.thelancet.com/lancet/aboutAbout The Lancet
https://www.elsevier.com/open-access/journal-embargo-finderJournal Embargo Finder
https://www.elsevier.com/open-accessOpen Access
Conflict: No
Refereed Source: Ulrichsweb
Sherpa Romeo Id: 31860
Divisions: 04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Article Processing Charge(s):
FeeCurrencyDate
5000USD2015
5000USD2016
5000USD2017
5000USD2018
R&P Contract available?: Yes
R&P Contract Details:
Contract Name/TitlePeriod of validityContract ID or numberURL of web page
ScienceDirect01.01.2024-31.12.2024Elsevier2024
Date Deposited: 10 Feb 2017 10:57
Last Modified: 26 Sep 2024 00:15
URI: https://www.jdb.uzh.ch/id/eprint/39014

Actions (login required)

  • Edit Item Edit Item